Irina S. Pylaeva

Irina S. Pylaeva

Auto-generated profile, based on publicly available information

Irina S. Pylaeva

Department of Economics, George Mason University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Journal of Cleaner Production
Verified
Journal Article
Open access
IPIrina S. Pylaeva
Irina S. Pylaeva
Mariya PodshivalovaMariya Podshivalova
Mariya Podshivalova
Andrew AlolaAndrew Alola
Andrew Alola
DPDmitrii V. Podshivalov
Dmitrii V. Podshivalov
ADAlexander A. Demin
Alexander A. Demin

10 June 2021 in Voprosy Ekonomiki
Verified
Journal Article
Closed access
PDF file
Mariya PodshivalovaMariya Podshivalova
Mariya Podshivalova
ИПИ. С. Пылаева
И. С. Пылаева
SAS. K. Almrshed
S. K. Almrshed
InnoThe article examines the specifics of innovative activity of Russian drug manufacturers, which in the context of a COVID-19 pandemic become a matter of national security. The research is based on panel data: out of a total of 1,816 enterprises in the industry, a sample of 345 innovatively active enterprises is formed with a time series of data 20 years long. The sample is diversified by the scale of enterprise activity into 4 groups: micro enterprises, small, medium, and large enterprises. These types of enterprises are compared both in absolute terms — size of investments in intangible assets, age, and in relative ones — frequency of investments in innovations, coefficient of autonomy, profitability of sales and assets, share of intangible assets in revenue and assets. The analysis was supplemented by enterprises not included in the sample to identify the effectiveness of innovation in the industry. The result is the innovative profile of industrial enterprises in the context of the scale of their activities. The conclusion is drawn about the specifics of the domestic pharmaceutical industry innovation activity, which generally coincides with the established distribution of roles in the global pharmaceutical industry, when large enterprises are leaders in the innovations development and implementation. Russian large companies also tend to use micro enterprises to implement risky projects. The authors conclude that in Russia, the foundations have been formed for transition to a new model of pharmaceutical industry innovative development. This model is based on cooperation of small and large businesses.

9 October 2022 in Voprosy Ekonomiki
Verified
Journal Article
Closed access
PDF file
IPI. S. Pylaeva
I. S. Pylaeva
Mariya PodshivalovaMariya Podshivalova
Mariya Podshivalova
DPD. V. Podshivalov
D. V. Podshivalov
Nowadays there are two perspectives on the COVID-19 pandemic: it has become a threat to sustainable economic development and the pharmaceutical industry has turned out to be its main beneficiary. The purpose of this article is to empirically verify the correctness of these statements. The data sample consists of 1771 enterprises of Russian pharmaceutical industry over a 14-year period. The methods used consisted of positioning maps and pairwise comparison of the financial indicators for 2020 with the two most severe crises in the Russian economy (2009 and 2015), as well as with the period of the most sustainable development (2007) and the legacy year (2019). In order to assess the uniformity of the pandemic impact on the industry, we identified analytical groups based on the scale of enterprises and life cycle stages. The main result is to reveal the uneven pandemic impact on the sustainable development of pharmaceutical industry producers. Small young companies were the main beneficiaries of the pandemic. The micro-enterprises in the pharmaceutical industry were the most severely affected. However, the analysis has shown that the pandemic was not the main cause of their instability. In addition, the study as a whole proves the presence of a certain stress resistance of domestic pharmaceutical producers to crises of various nature.

26 May 2026 in Journal of Economic and Administrative Sciences
Verified
Journal Article
Closed access
IPIrina Pylaeva
Irina Pylaeva
MPMariya Podshivalova
Mariya Podshivalova
Andrew AlolaAndrew Alola
Andrew Alola
Purpose: The aim of this study is twofold. First, it seeks to reveal aspects of the relationship between business demographics and societal attitudes toward entrepreneurship. Second, it aims to investigate whether the direction of causality in this nexus of indicators varies across countries. Accordingly, two research questions are raised: Is there a link between firm birth and death rates and social perspectives? Does the direction of causality between societal attitudes and business demographic statistics vary across countries? Design/methodology/approach: To answer these questions, we applied regression models in conjunction with the Granger causality test on a sample of 37 countries – 34 OECD-database countries including the EU-27 (except Malta), Ireland, North Macedonia, Norway, Serbia, South Korea, Switzerland, Turkey, and the United Kingdom. We supplemented this sample with national statistics from Israel, the United States, and Australia, using data from 2001 to 2021. We selected Global Entrepreneurship Monitor (GEM) indicators, such as fear of failure, entrepreneurial intentions, and viewing entrepreneurship as a good career choice as indicators of societal attitudes toward entrepreneurship. Findings: The results support the hypotheses and reveal the link between societal attitudes and business demographics. The study shows that entrepreneurial intention has a positive statistically significant association with firm birth rates, rather than a fear of failure. For the first time, we found evidence of a positive lagged effect of firm birth and death rates on entrepreneurial intentions. Additionally, there is evidence that the direction of causality varies across countries. Originality/value: This study adds sheds new light on the intention-to-action gap by examining lagged variables and emphasizing the diversity and uniqueness of social environments in seemingly economically similar countries.